Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 December 2021 | Story Nonsindiso Qwabe
Christa Faber
Innovative Methods in Assessment Practices award winner for the Qwaqwa Campus, Christa Faber.

By working with students and being part of their development into successful young adults, Mathematics and Applied Mathematics Lecturer on the Qwaqwa Campus, Christa Faber, soon realised that she would like to proceed with her own studies, and she set her sights on just that. Obtaining her honours degree in Mathematical Statistics at age 40 inspired Faber to continue pursuing an education. She will be receiving her Master of Higher Education Studies degree during the December graduations.

Teaching has always been her passion, Faber shared fondly. She commenced her teaching career as a Mathematics teacher in a small town, Molteno, in the Eastern Cape. After four years of teaching, she worked as a Mathematics supply teacher in the United Kingdom for two years. Upon her return, she continued her teaching career in Harrismith, where she was appointed as a Science teacher at Harrismith High School, before receiving an offer to assist the UFS Qwaqwa Campus as a Statistics facilitator in 2003. She never looked back.

As a researcher, Faber has spent the past eight years using technology as an educational tool to determine whether it can be used to improve students’ performance and understanding of basic statistics. “I believe students learn best when they expect to be successful and see the value of the course for their personal development,” she said.

Faber conducted an experiment on how an online assessment tool (OAT) could be incorporated into the Statistics module to enhance student engagement, and consequently, the performance of students in a rural setting. The transition from face-to-face teaching to online learning has been a topic across all institutions of higher learning, with students’ response to learning on blended platforms being of great importance.

The learning experiment, conducted pre-COVID, showed the benefits that online assessment tools could have on the performance and engagement of students at a rural university. Faber said she considers it important to know how students engaged in key online and general learning practices as a way of managing and developing rural university education. For the experiment, a pragmatic parallel mixed methods design was used to divide students into two groups to compare the performances of those with online assessment tool interventions and those without.

The intervention recently won Faber the Innovative Methods in Assessment Practices award for the Qwaqwa Campus at this year’s Centre for Teaching and Learning awards. The purpose of the category was to showcase how assessment strategies, tools, and assessment activities are used to assess students in new, original, or inventive ways. She said she was grateful to receive recognition for a research project inspired by her passion for teaching and learning, combined with the use of online assessment technology, to enhance students’ learning experience in the field of statistics. “My ongoing research supports the promotion of student engagement in statistics education, as well as in the general educational field.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept